#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multiple system atrophy Chronic myeloid leukaemia (in remission) Uveitis Pyoderma gangrenosum Anal cancer Mantle cell lymphoma recurrent Obesity Arginase deficiency ROHHAD syndrome Retinopathy proliferative Frostbite Squamous cell carcinoma of the hypopharynx B-cell small lymphocytic lymphoma recurrent Oesophageal squamous cell carcinoma Alport's syndrome More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Life with Disease Wolfram syndrome – Basic Information Thrombotic thrombocytopenic purpura – Diagnostics Piriformis syndrome – Life with Disease Antithrombin III deficiency – Basic Information Congenital hypotransferrinaemia – Life with Disease Richter’s syndrome – Trials in Disease Aicardi-Goutieres syndrome Myelodysplastic syndrome with excess blasts – Treatment Waldenstrom’s macroglobulinaemia recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dapansutrile Tirzepatide Doxecitine Ketamine Hydrochloride Rusfertide Domperidone Sapablursen Brexpiprazole Clonidine Hydrochloride RO7268489 Ag-946 Phosphate Fluorodopa (18F) Cdr132L Testosterone Methotrexate Sodium Fedratinib Acemetacin Islatravir Ly3298176 Sym024 More therapies…

    Learn about Your Condition

    Pulmonary sarcoidosis Palmoplantar pustulosis Vertigo Oral herpes Hypogonadism male Haemorrhage prophylaxis Tricuspid valve disease Cerebellar ataxia Conjunctivitis allergic Drug dependence Leber's congenital amaurosis Incontinence Skin ulcer Dengue fever Angelman's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Disitamab Vedotin alone or with Pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Disitamab Vedotin
    Belgium France Italy Spain

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study Comparing Teriparatide and Alendronate for Preventing Bone Fractures in Women Over 65 with Fragile Bones

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • ALENDRONATE SODIUM TRIHYDRATE
    • Teriparatide
    Spain

  • Study Comparing Secretin Synthetic Human and Endoscopic Aspiration Techniques for Analyzing Pancreatic Cancer in Patients with Intraductal Papillary Mucinous Neoplasia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Intraductal papillary mucinous neoplasm
    Investigated Drugs:
    • SECRETIN SYNTHETIC HUMAN
    Spain

  • Study on Fosfomycin for Treating Acute Bacterial Prostatitis in Patients with Multidrug-Resistant E. coli

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    • Prostatitis Escherichia coli
    Investigated Drugs:
    • Fosfomycin
    Spain

  • Study on Ursodeoxycholic Acid to Prevent Recurrence of Acute Biliary Pancreatitis in Patients After Gallstone-Related Episode

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Obstructive pancreatitis
    • Pancreatitis acute
    Investigated Drugs:
    • Ursodeoxycholic Acid
    Spain

  • Study on Platelet Concentrate for Treating Tennis Elbow in Patients: Comparing Surgery and Injection Methods

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Epicondylitis
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study Comparing Sodium Chloride and Lactated Ringer’s Solution for Patients with Acute Pancreatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatitis acute
    Investigated Drugs:
    • Sodium Lactate Solution
    • Calcium Chloride Dihydrate
    • Potassium Chloride
    France Spain

  • Study of Disitamab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer Expressing HER2

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Disitamab Vedotin
    • Pembrolizumab
    Belgium Hungary Italy Spain

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Cholesterol
    • Sphingomyelin (Egg)
    • Sodium Chloride
    Belgium Czechia France Greece Hungary Latvia +3
Previous Page
1 … 10 11 12 13 14 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!